Underlying co-morbidities were observed in 33 (66%) CP recipients in all three categories including asthma in 1 (2%), malignancy in 1 (2%), diabetes in 5 (10%), hypertension in 10 (20%), diabetes + hypertension in 13 (26%) and 03(6%) had hypertension +ischemic heart disease (IHD). This evidence concerns the gene CP and myocardial ischemia.